No association was noted between IGF-I, IGFBP-3, IGF-I : IGFBP-3 molar ratio, or IGF-II and risk of pancreatic cancer when 2, 4, 6, or 8 years were required between plasma collection and cancer diagnosis (Table 4). Here, IGFBP3 is linked to cancer.